Hemoperfusion and blood purification strategies in patients with COVID-19: A systematic review.

Filippo Sanfilippo Gennaro MartucciLuigi La ViaGiuseppe CuttoneGiorgio DimarcoCarla PulizziAntonio ArcadipaneMarinella Astuto

Published in: Artificial organs (2021)

Our review does not support strong conclusions regarding the role of HP in COVID-19. Considering the very low level of clinical evidence detected, starting HP therapies in COVID-19 patients does not seem supported outside of clinical trials. Prospective randomized data are needed.

Keyphrases

sars cov
clinical trial
double blind
coronavirus disease
phase ii
open label
phase iii
electronic health record
placebo controlled
respiratory syndrome coronavirus
big data
study protocol
septic shock
deep learning
machine learning